Assessment of the proliferative CLL signature using Ki67 demonstrated a significant decrease in CLL proliferation upon inhibition of CD38 enzymatic activity (Figures 3B and 3C). Here, MKI67 is linked to B-cell chronic lymphocytic leukemia.